JFK MEDICAL CENTER — History
CCN 100080 | 3-year financial timeline | COVID resilience: 47/100
🛡️ Public data only — no PHI permitted on this instance.
$688M
Latest Revenue (FY2022)
+6.5%
Revenue CAGR (3yr)
13.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $607M | $653M | $688M | +5.5% | +6.5% |
| Operating Expenses | $518M | $583M | $597M | +2.4% | +7.3% |
| Operating Margin | 14.6% | 10.7% | 13.3% | +24.1% | -4.7% |
| Net Income | $89M | $70M | $91M | +30.9% | +1.5% |
| Licensed Beds | 672 | 616 | 582 | -5.5% | -6.9% |
| Total Patient Days | 137,518 | 145,249 | 145,882 | +0.4% | +3.0% |
| Medicare Day % | 23% | 22% | 21% | -1.6% | -3.1% |
| Medicaid Day % | 8% | 7% | 5% | -30.5% | -18.6% |
COVID Impact & Recovery
Resilience Score: 47/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +13.4% ($607M → $688M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.5%
This Hospital
+7.6%
State Avg
Latest Margin
13.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $729M | 12.6% |
| FY2024 (proj) | $770M | 12.0% |
| FY2025 (proj) | $810M | 11.3% |